PI3K and AKT: Unfaithful Partners in Cancer

by Seraina Faes, Olivier Dormond
Published 2015-09-01

Resistance to mTORC1 Inhibitors in Cancer Therapy: From Kinase Mutations to Intratumoral Heterogeneity of Kinase Activity

by Seraina Faes, Nicolas Demartines, Olivier Dormond
Published 2017-01-01

Mechanistic Target of Rapamycin Inhibitors in Renal Cell Carcinoma: Potential, Limitations, and Perspectives

by Seraina Faes, Nicolas Demartines, Olivier Dormond
Published 2021-03-01

Evolving Significance and Future Relevance of Anti-Angiogenic Activity of mTOR Inhibitors in Cancer Therapy

by Seraina Faes, Tania Santoro, Nicolas Demartines, Olivier Dormond
Published 2017-11-01